article thumbnail

Cyfendus Anthrax Vaccine Wins FDA Approval

XTalks

Kelly Warfield, Emergent’s senior vice president, science and development, in the company’s press release. Anthrax is a rare, yet severe disease caused by the bacterium B. Additionally, 533 participants received at least one dose of the comparator-licensed anthrax vaccine, BioThrax (Anthrax Vaccine Adsorbed). What Is Anthrax?

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, the FDA proceeded to grant official licensing for Moderna’s Spikevax COVID-19 vaccine.

Sales 98